IQ-AI Ltd
LSE:IQAI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novo Nordisk A/S
CSE:NOVO B
|
DK |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its Industry Average (314.2), the stock would be worth GBX-42.36 (5 235% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -6.1 | GBX0.83 |
0%
|
| Industry Average | 314.2 | GBX-42.36 |
-5 235%
|
| Country Average | 0.1 | GBX-0.01 |
-102%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| JE |
|
IQ-AI Ltd
LSE:IQAI
|
2m GBP | -6.1 | -1.9 | |
| JP |
|
Medical Data Vision Co Ltd
TSE:3902
|
37.9T JPY | 135.4 | 227.5 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 21.9 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
26.4B USD | 20 | 29 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.5B AUD | 76.3 | 61.6 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 10 | 20.5 | |
| SE |
|
Sectra AB
STO:SECT B
|
51.8B SEK | -133.5 | 96.4 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.9B USD | 15.2 | 42.4 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.4B USD | 14.7 | 18.6 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
19.3B CNY | -122.4 | -62.7 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 267.9 | -328 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.1 |
| Median | 0.1 |
| 70th Percentile | 2.5 |
| Max | 314.2 |
Other Multiples
IQ-AI Ltd
Glance View
IQ-AI Ltd. is a holding company, which engages in the provision of clinical treatments to patients in the field of medical imaging diagnostics. The firm provides health care technology solutions to the artificial intelligence (AI) medical imaging market. Through its subsidiary, StoneChecker Software Ltd, It offers medical imaging software for urolithiasis that analyses and presents stone metrics, including stone size, volume, density, skin to stone distance, and stone architecture through TexRAD analysis within the healthcare information technology (IT) systems. Through its subsidiary, Imaging Biometrics, LLC, It specializes in the design and manufacture of visualization tools, the application of machine learning and AI software solutions, and the development and clinical testing of imaging endpoints and biomarkers. Its portfolio consists of IB Neuro and IB Diffusion that are used in treatment of brain tumors, strokes and pathologies.
